OncoDiversity Foundation

What OncoDiversity Foundation does

OncoDiversity Foundation is a Canadian nonprofit organization dedicated to advancing equitable cancer care for 2SLGBTQI+ communities. Founded by Dr. Jean-Marc Bourque, an Associate Professor of Radiation Oncology at the Centre hospitalier de l'Université de Montréal (CHUM), the organization is headquartered in Montreal and operates across Canada. Its mission is to address unique challenges that queer and trans people face in oncology through advocacy, education, inclusive research, and clinical service delivery, with a stated focus on discrimination in healthcare settings, lack of affirming care, data gaps on cancer outcomes for sexual and gender minorities, and structural inequities in cancer care systems.

The organization's portfolio comprises four principal offerings: Canada's first national 2SLGBTQI+ cancer conference (scheduled June 11-12, 2026 at the Pierre-Péladeau Amphitheater at CHUM); a specialized Trans Cancer Clinic at CHUM providing gender-affirming oncology services, described as Canada's first such clinic; patient-facing educational resources hosted on oncodiversite.ca; and the Montreal Declaration on 2SLGBTQI+ Cancer Equity, a strategic policy framework. It serves three primary constituencies: 2SLGBTQI+ patients and communities (primary), healthcare professionals and researchers (primary), and policymakers and health-system leaders (secondary). Distribution is through the annual conference, direct clinic delivery at CHUM, and self-serve online resources.

The business model is nonprofit, with revenue generated through donations, grants, sponsorship partnerships, and conference fees; specific pricing and budget figures are not publicly disclosed. Go-to-market is community-led advocacy and education, anchored by the annual conference as the primary engagement vehicle and supported by a partner network that includes CHUM, Princess Margaret Cancer Centre (UHN), Community-Based Research Centre (CBRC), CARTaGENE, the Canadian Cancer Trials Group (CCTG), Queering Cancer, and international collaborators including the UK's UCATS, OUTpatients UK, and the European Cancer Organisation. The organization has no disclosed funding rounds, no reported headcount, and no proprietary technology stack; its intellectual assets are concentrated in the founder's clinical-academic profile and the first-mover brand positioning in Canadian 2SLGBTQI+ oncology.

Name

OncoDiversity Foundation

Legal name

OncoDiversity

Website

https://oncodiversite.ca

Company type

Private

Operating status

Operating

Short description

OncoDiversity Foundation is a Canadian nonprofit that advances equitable cancer care for 2SLGBTQI+ communities through advocacy, education, inclusive research, and a specialized Trans Cancer Clinic at CHUM in Montreal, anchored by Canada's first national 2SLGBTQI+ cancer conference in June 2026.

Ownership category

akta.pro rank

Product category

Healthcare Nonprofit Advocacy

NAICS

Ambulatory Health Care Services (621), Social Assistance (624), Other Individual and Family Services (624190)

SIC

Services-Health Services (8000), Services-Social Services (8300)

akta.pro primary industry

Disability Services & Independent Living Support (BPAGACAG)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Cancer care equity
• 2SLGBTQI+ health advocacy
• Oncology education
• Patient advocacy resources
• Healthcare research

Headquarters

HQ city

Montreal

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Nonprofit Funding Model: As a nonprofit organization, OncoDiversity generates revenue through donations, grants, sponsorship partnerships, and conference fees. The organization is dedicated to advancing equity in cancer care and operates as a charitable entity in Canada.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

OncoDiversity Foundation is a Canadian nonprofit that advances equitable cancer care for 2SLGBTQI+ communities through advocacy, education, research, and clinical services. Its core offerings include a national 2SLGBTQI+ cancer conference, a specialized Trans Cancer Clinic at CHUM, patient education resources, and policy initiatives such as the Montreal Declaration on 2SLGBTQI+ Cancer Equity. The organization brings together patients, healthcare professionals, researchers, and policymakers to address the unique challenges queer and trans people face in oncology.

Product overview

OncoDiversity Foundation is a nonprofit organization offering a portfolio of advocacy, education, and clinical initiatives focused on advancing equitable cancer care for 2SLGBTQI+ communities in Canada. Its core offerings include Canada's first national 2SLGBTQI+ Cancer Conference (scheduled for June 2026 in Montreal), a specialized Trans Cancer Clinic partnership at CHUM providing gender-affirming oncology services, patient education resources, and policy initiatives including the Montreal Declaration on 2SLGBTQI+ Cancer Equity. The organization operates at the intersection of healthcare delivery, research, and community advocacy.

Differentiator

Problem solved

Functional benefit

Products and services

• Canada's First 2SLGBTQI+ Cancer Conference A national conference dedicated to 2SLGBTQI+ inclusion in oncology and cancer care, bringing together healthcare providers, researchers, policymakers, and community partners to explore equitable, affirming, and evidence-based systems of care.
• Trans Cancer Clinic (CHUM) Canada's first specialized oncology clinic for transgender and non-binary individuals, providing gender-affirming cancer care led by Olivier Landry at CHUM in Montreal.
• Patient Resources Educational materials and resources for 2SLGBTQI+ patients navigating cancer care across the cancer continuum from prevention and screening to survivorship and palliative care.
• Montreal Declaration on 2SLGBTQI+ Cancer Equity A strategic policy framework developed through workshop collaboration aimed at advancing 2SLGBTQI+ cancer equity nationally in Canada.

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Nine partnerships are on record, tiered core, flagship and minor.

• Queering CancercoreStrategic or Co-development PartnerQueering Cancer is a Canadian initiative co-led by Dr. Amanda Bolderston and Kim Meeking, dedicated to improving cancer care for 2SLGBTQ+ communities through advocacy, education, and knowledge mobilization. Both co-leads are featured speakers at OncoDiversity's conference.
• Community-Based Research Centre (CBRC)coreStrategic or Co-development PartnerCBRC is a national nonprofit dedicated to promoting the health of people of diverse sexualities and genders through community-led research. OncoDiversity features CBRC leaders including Michael Kwag (Executive Director), Lane Bonertz (Associate Director, Two-Spirit Health), and Marie Geoffroy (Associate Director of Research) as speakers.
• CHUM (Centre hospitalier de l'Université de Montréal)coreStrategic or Co-development PartnerCHUM is the primary hospital affiliation for Dr. Jean-Marc Bourque (Founder & Executive Director) and hosts the Pierre-Péladeau Amphitheater conference venue. The organization is integral to OncoDiversity's operations and hosts Canada's first specialized Trans Cancer Clinic.
• Princess Margaret Cancer CentrecoreStrategic or Co-development PartnerPrincess Margaret Cancer Centre (UHN) is a major cancer center with an established Sexual and Gender Diversity in Cancer Care Program led by Dr. Christian Schulz-Quach and Margo Kennedy. Dr. Gary Ko serves as a breast surgeon there. Multiple OncoDiversity speakers are affiliated with this center.
• OUTpatients (UK)flagshipStrategic or Co-development PartnerOUTpatients is the UK's LGBTIQ+ cancer charity, founded by Stewart O'Callaghan. This is the UK's only LGBTIQ+ cancer charity and provides a model for Canadian 2SLGBTQI+ cancer advocacy. Stewart O'Callaghan is a virtual speaker at OncoDiversity's conference.
• UK Cancer and Transition Service (UCATS)flagshipStrategic or Co-development PartnerUCATS is a world-first national clinic in the UK that integrates oncology and gender-affirming care for transgender and gender diverse people. Led by Dr. Alison May Berner, it serves as a model for CHUM's Trans Cancer Clinic in Canada. Dr. Berner is a featured speaker and moderator at OncoDiversity's conference.
• European Cancer Organisation (ECO)minorStrategic or Co-development PartnerECO is a European organization working on cancer care inequalities. Dr. Nicolò Battisti serves as Chair of ECO's Inequalities Network & LGBTQI+ Subgroup and is a virtual speaker at OncoDiversity's conference.
• Canadian Cancer Trials Group (CCTG)minorStrategic or Co-development PartnerCCTG is Canada's cancer clinical trials organization. Anna Johnson serves as EDIIA (Equity, Diversity, Inclusivity, Indigenization, and Accessibility) Lead and is a speaker at OncoDiversity's conference.
• CARTaGENEminorStrategic or Co-development PartnerCARTaGENE is Quebec's largest population-based prospective cohort and a member cohort of Canada's largest prospective cohort study (CanPath). Dr. Vikki Ho serves as Co-Scientific Director and is a featured speaker at OncoDiversity's conference.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Community-Based Research Centre (CBRC): Canadian national nonprofit promoting health of people of diverse sexualities and genders through community-led research. Broader LGBTQ+ health mandate with overlapping research and advocacy functions.
• Canadian Cancer Society: Canada's largest national cancer charity, funding research and support services. Broader incumbent with overlapping equity and survivorship programs but not focused on 2SLGBTQI+ populations.

Direct peers

• Queering Cancer: Canadian initiative co-led by Dr. Amanda Bolderston and Kim Meeking, focused on improving cancer care for 2SLGBTQ+ communities through advocacy and education. Closest Canadian peer and a named strategic partner.
• National LGBT Cancer Network (US): US-based nonprofit improving LGBT cancer outcomes through education, training, advocacy, and survivorship programs. Direct mission-aligned peer operating in a different geography.
• Princess Margaret Cancer Centre SGM Program: Hospital-based Sexual and Gender Diversity in Cancer Care Program led by Dr. Christian Schulz-Quach at UHN. Direct peer in clinical and educational services for 2SLGBTQI+ oncology patients and a named partner.
• UK Cancer and Transition Service (UCATS): World-first national clinic integrating oncology and gender-affirming care for trans and gender diverse people, led by Dr. Alison May Berner. Direct clinical model peer for OncoDiversity's Trans Cancer Clinic.
• OUTpatients UK: UK's only LGBTIQ+ cancer charity, founded by Stewart O'Callaghan. Direct peer in mission and advocacy focus, and explicitly identified as a model partner for OncoDiversity.

Regional players

• LGBT Foundation: UK-based charity providing health and wellbeing services to LGBTQ+ communities. Operates in an overlapping space with comparable offering, but primarily serves the UK rather than Canada.

Emerging players

• European Cancer Organisation (ECO) Inequalities Network: European body addressing cancer care inequalities, including an LGBTQI+ subgroup chaired by Dr. Nicolò Battisti. Overlapping advocacy and policy focus at a regional level.
• Rainbow Health Ontario: Canadian organization promoting LGBTQ+ health through training, resources, and policy change. Overlapping mandate in provider education and health-system advocacy, but not cancer-specific.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OncoDiversity Foundation